Old Republic International
ORI NYSE Property & Casualty Insurance Financials FY2016βFY2025
Old Republic International's revenue rose 11.0% to $9.1 billion in fiscal 2025. Its net margin was 10.2%, down from 10.4% a year earlier. It paid out $906 million in dividends and buybacks. The diluted share count fell 4.4%.
What Old Republic International does
No business description yet.
- Legal name
- OLD REPUBLIC INTERNATIONAL CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000074260-26-000008
0000074260
Revenue and margins
Old Republic International had $9.1B of revenue in fiscal 2025, up 11.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Old Republic International returned $906M to shareholders in fiscal 2025. The diluted share count fell 4.4%.
Value Old Republic International yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 251.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 8.5x Β· peers 12.7x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Old Republic International can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $724M | $942M | $1.2B | $1.6B | $1.9B |
| Interest coverage | 35.4x | 13.7x | 12.1x | 14.4x | 17.8x |
| Total assets | $25.0B | $25.2B | $26.5B | $27.8B | $29.9B |
| Total liabilities | $18.1B | $19.0B | $20.1B | $22.2B | $23.9B |
| Shareholders' equity | $6.9B | $6.2B | $6.4B | $5.6B | $5.9B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.1M
2 insiders
Sold, 12 months
$2.5M
3 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Carolyn MonroeSVP - Title Insurance | Sold | 4,386 | $42.01 | $0.2M | Form 4 |
| Aug 11, 2026 | Carolyn MonroeSVP - Title Insurance | Sold | 1,788 | $42.26 | $0.1M | Form 4 |
| Jul 29, 2026 | Jeffrey LangeSVPUnderwriting & Distribution | Sold | 14,075 | $43.76 | $0.6M | Form 4 |
| Jul 28, 2026 | Stephen J OberstExecutive Vice President | Sold | 13,125 | $43.96 | $0.6M | Form 4 |
| May 12, 2026 | Carolyn MonroeSVP - Title Insurance | Sold | 13,330 | $38.76 | $0.5M | Form 4 |
| May 1, 2026 | Therace RischDirector | Bought | 300 | $39.90 | $0.0M | Form 4 |
| Mar 2, 2026 | John Eric SmithDirector | Bought | 1,135 | $43.10 | $0.0M | Form 4 |
| Feb 2, 2026 | Carolyn MonroeSVP - Title Insurance | Sold | 5,526 | $39.28 | $0.2M | Form 4 |
| Nov 14, 2025 | Carolyn MonroeSVP - Title Insurance | Sold | 6,680 | $44.54 | $0.3M | Form 4 |
| Nov 3, 2025 | Therace RischDirector | Bought | 1,000 | $39.14 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β1.1% | β1.4% | β0.8% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Old Republic International ORI | $9.6B | 11.0% | β | β | β | 8.5x | β | |
| Cincinnati Financial CINF | $27.4B | 11.4% | β | 24.5% | 17.1% | 8.3x | β | Compare β |
| Hanover Insurance THG | $8.5B | 5.7% | 14.2% | 17.8% | 21.3% | 11.4x | β | Compare β |
| Fidelity National Financial FNF | $10.8B | 5.6% | β | β | β | 14.0x | β | Compare β |
| W. R. Berkley WRB | $28.7B | 7.8% | β | β | β | 15.1x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.9B | $6.3B | $6.3B | $7.5B | $7.2B | $9.3B | $8.1B | $7.3B | $8.2B | $9.1B |
| Interest expense | $50.9M | $64.5M | $47.2M | $43.2M | $42.5M | $55.9M | $67.3M | $67.2M | $79.8M | $70.5M |
| Pretax income | $686M | $725M | $438M | $1.3B | $688M | $1.9B | $857M | $747M | $1.1B | $1.2B |
| Income tax | $219M | $165M | $67.5M | $266M | $130M | $388M | $171M | $149M | $217M | $242M |
| Net income | $467M | $561M | $371M | $1.1B | $559M | $1.5B | $686M | $599M | $853M | $935M |
| Diluted EPS | $1.62 | $1.92 | $1.24 | $3.51 | $1.87 | $5.05 | $2.26 | $2.10 | $3.24 | $3.72 |
| Diluted shares | 0.30B | 0.30B | 0.30B | 0.30B | 0.30B | 0.30B | 0.30B | 0.29B | 0.26B | 0.25B |
| Cash flow | ||||||||||
| Cash from operations | $637M | $453M | $761M | $936M | $1.2B | $1.3B | $1.2B | $880M | $1.2B | $1.2B |
| Depreciation and amortization | $29.6M | $27.2M | $27.6M | $26.8M | $26.9M | $27.2M | $28.3M | $33.0M | $39.3M | $35.4M |
| Stock-based compensation | $3.1M | $3.5M | $3.8M | $3.7M | $2.1M | $3.2M | $9.0M | $19.5M | $33.2M | $46.7M |
| Acquisitions | $0.0M | $0.0M | $13.1M | $1.2M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $281M | $535M | $942M | $124M |
| Dividends paid | $194M | $199M | $499M | $539M | $250M | $1.0B | $580M | $276M | $272M | $783M |
| Dividends and buybacks | $194M | $199M | $499M | $539M | $250M | $1.0B | $861M | $811M | $1.2B | $906M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $827M | $796M | $455M | $563M | $868M | $724M | $942M | $1.2B | $1.6B | $1.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $18.6B | $19.4B | $19.3B | $21.1B | $22.8B | $25.0B | $25.2B | $26.5B | $27.8B | $29.9B |
| Total liabilities | $14.1B | $14.7B | $14.2B | $15.1B | $16.6B | $18.1B | $19.0B | $20.1B | $22.2B | $23.9B |
| Shareholders' equity | $4.5B | $4.7B | $5.1B | $6.0B | $6.2B | $6.9B | $6.2B | $6.4B | $5.6B | $5.9B |
| Margins | ||||||||||
| EBITDA margin | 13.0% | 13.1% | 8.2% | 18.7% | 10.6% | 21.5% | 11.8% | 11.7% | 14.4% | 14.1% |
| Net margin | 7.9% | 9.0% | 5.9% | 14.2% | 7.8% | 16.4% | 8.5% | 8.3% | 10.4% | 10.2% |
| Returns | ||||||||||
| Return on equity | 11.2% | 12.2% | 7.5% | 19.0% | 9.2% | 23.5% | 10.5% | 9.5% | 14.2% | 16.2% |
| Return on assets | 2.6% | 3.0% | 1.9% | 5.2% | 2.6% | 6.4% | 2.7% | 2.3% | 3.1% | 3.2% |
| Growth | ||||||||||
| Revenue growth | 2.3% | 6.2% | β0.1% | 19.2% | β4.0% | 30.4% | β13.5% | β10.2% | 13.4% | 11.0% |
| Net income growth | 10.6% | 20.1% | β33.9% | 185.1% | β47.1% | 174.7% | β55.3% | β12.8% | 42.5% | 9.7% |
| EPS growth | 9.5% | 18.5% | β35.4% | 183.1% | β46.7% | 170.1% | β55.3% | β7.1% | 54.3% | 14.8% |
| Share count change | 0.1% | 1.0% | 0.5% | 0.1% | β0.8% | 1.6% | β0.1% | β5.9% | β7.9% | β4.4% |
| Financial health | ||||||||||
| Interest coverage | 14.5x | 12.3x | 10.3x | 31.6x | 17.2x | 35.4x | 13.7x | 12.1x | 14.4x | 17.8x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.3% | 0.4% | 0.5% |
| Quality scores | ||||||||||
| Accruals ratio | β1.0% | 0.6% | β2.0% | 0.6% | β2.9% | 0.9% | β1.9% | β1.1% | β1.4% | β0.8% |
Source: SEC EDGAR XBRL filings (CIK 0000074260). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.